A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells

ConclusionsFrom our data we conclude that the mechanisms underlying hypoxia-induced CD133-mediated cisplatin resistance may be instrumental for the design of new GBM treatment strategies.

Source: Cellular Oncology - February 28, 2018 Category: Cancer & Oncology Source Type: research